Related Experiment Video
Updated: Feb 28, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
From co-creation to compounding value: A new model of rare disease science communication in China
1Wonder Sir: China's Pioneering Platform for Patient-driven Education and Innovation in Rare Diseases, Shanghai, China.
Abstract:
For the vast rare disease patient community in China, science communication is crucial for bridging the information gap. However, the traditional, expert-led knowledge distribution model has proven insufficient to address the dual challenges of resource scarcity and low efficiency in the rare disease field. This paper introduces a new science communication model derived from practice in China. With "Patient-Driven Co-Creation" as its core, this model's ultimate goal transcends traditional information dissemination, aiming to empower the entire ecosystem through systematic value creation. Through an analysis of the practical model of the Wonder Sir platform, this paper proposes for the first time the "Patient Compounding Value Model". This model demonstrates how intangible patient-lived experiences can be systematically transformed into tangible assets capable of driving scientific research, clinical optimization, and public policy, thereby providing a sustainable value-generation mechanism for the resource-scarce rare disease field.
More Related Videos
08:17Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016
07:31Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e
Published on: February 17, 2023
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Single Nucleotide Polymorphisms-SNPs